Cell lines of hyperdiploid myeloma, are we there yet?

被引：2
|
作者：
Chng, Wee J. [1 ]
Fonseca, Rafael [1 ]
机构：
[1] Mayo Clin, Ctr Comprehens Canc, Div Hematol Oncol, Scottsdale, AZ USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 140卷 / 05期
关键词：
hyperdiploid; multiple myeloma; cell lines; gene expression; array comparative genomic hybridization;
D O I：
10.1111/j.1365-2141.2007.06905.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：579 / 580
页数：3
相关论文
共 50 条
  • [1] Cell lines of hyperdiploid myeloma, are we there yet? - response to Chng & Fonseca
    Yaccoby, Shmuel
    Zhan, Fenghuang
    Shaughnessy, John
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (05) : 580 - 581
  • [2] Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines
    Li, Xin
    Pennisi, Angela
    Zhan, Fenghuang
    Sawyer, Jeffrey R.
    Shaughnessy, John D.
    Yaccoby, Shmuel
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (06) : 802 - 811
  • [3] VOLIN and KJONTwo novel hyperdiploid myeloma cell lines
    Vatsveen, Thea Kristin
    Borset, Magne
    Dikic, Aida
    Tian, Erming
    Micci, Francesca
    Lid, Ana H. B.
    Meza-Zepeda, Leonardo A.
    Coward, Eivind
    Waage, Anders
    Sundan, Anders
    Kuehl, W. Michael
    Holien, Toril
    GENES CHROMOSOMES & CANCER, 2016, 55 (11): : 890 - 901
  • [4] Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines (vol 138, pg 802, 2007)
    不详
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (04) : 475 - 475
  • [5] Exploitation of novel hyperdiploid and nonhyperdiploid myeloma cell lines for studying innovative interventions for myeloma and its associated bone disease.
    Pennisi, Angela
    Li, Xin
    Zangari, Maurizio
    Sawyer, Jeffrey R.
    Zhan, Fenghuang
    Barlogie, Bart
    Shaughnessy, John
    Yaccoby, Shmuel
    BLOOD, 2007, 110 (11) : 168A - 169A
  • [6] Comparison of Multiple Myeloma Donor Patient Samples and Derived Cell Lines Identifies a Confirmed Hyperdiploid Myeloma Cell Line and Demonstrates Remarkable Genetic Similarity Between Cell Lines and Patient Samples.
    Keats, Jontathan J.
    Arendt, Bonnie K.
    Braggio, Esteban
    Barrett, Michael
    Price-Troska, Tammy
    Fonseca, Rafael
    Bergsagel, P. Leif
    Jelinek, Diane F.
    BLOOD, 2008, 112 (11) : 944 - 944
  • [7] Risk stratification in multiple myeloma: Are we there yet?
    Mohan, Meera
    Schinke, Carolina
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1585 - 1587
  • [8] Minimal Residual Disease in Myeloma: Are We There Yet?
    Hart, Andrew J.
    Jagasia, Madan H.
    Kim, Annette S.
    Mosse, Claudio A.
    Savani, Bipin N.
    Kassim, Adetola
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1790 - 1799
  • [9] Precision medicine in multiple myeloma: are we there yet?
    Auclair, Daniel
    Lonial, Sagar
    Anderson, Kenneth C.
    Kumar, Shaji K.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (02): : 51 - 53
  • [10] Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
    Hata, H
    Matsuzaki, H
    Yoshida, M
    Sonoki, T
    Kuribayashi, N
    Nagasaki, A
    Kimura, T
    Harada, N
    Takatsuki, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (02) : 219 - 226
12345